In vitro characterization is classically done on cloned human receptors expressed in cell lines (HEK293, CHO) via cAMP measurements (ELISA, FRET) or beta-arrestin recruitment (BRET, NanoBiT)
GLP-1 Pipeline Update: May 2026 Quarterly view of the GLP-1 pipeline and anticipated indications Editorial team Maryam Tabatabai, PharmD Editor-In-Chief Associate Vice President, Clinical Information Carole Kerzic, RPh Executive Editor Drug Information Pharmacist Principal Nicole Kjesbo, PharmD, BCPS Executive Editor Clinical Program Development Director Senior, Pipeline DISCLAIMER The drug pipeline is fluid
What to Expect From Treatment Getting Started Starting GLP-1 therapy for sleep improvement involves several steps: Medical evaluation to assess your sleep problems and overall health Sleep study to diagnose the type and severity of sleep issues Baseline measurements of weight, blood sugar, and other health markers Medication selection based on your specific needs and insurance coverage Timeline for Improvement Most people notice sleep improvements gradually: Weeks 1-4: May notice slight appetite reduction and early weight loss Months 1-3: More noticeable weight loss and some sleep quality improvement Months 3-6: Significant weight reduction and marked sleep improvement 6+ months: Maximum sleep benefits as weight loss continues Combining with Other Treatments GLP-1 medications work best when combined with healthy lifestyle changes: Regular exercise to support weight loss and better sleep Balanced diet to maximize medication effectiveness Good sleep hygiene practices Stress management techniques For complex sleep issues, you may also need specialized care from our sleep problems specialists
On the oral small-molecule front, Ascletis reported placebo-adjusted weight reductions of 5.4 percent to 7.7 percent at 13 weeks in a US Phase 2 study, with no plateau in weight loss observed
